Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Analysis of the ubiquitin-modified proteome identifies novel host factors in Kaposi’s sarcoma herpesvirus lytic reactivation

Journal of Virology(2024)10.1128/jvi.01224-24Source: DataRank Database

Analysis of the ubiquitin-modified proteome identifies novel host factors in Kaposi’s sarcoma herpesvirus lytic reactivation is a research paper published in Journal of Virology (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.63)OA: hybridTopics (69)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Mathew Constantine,Jessica Oswald ORCID,Anna J. Dellomo ORCID,Bronwyn Masters,Esosa Omorogbe ORCID

Live enrichment

PubMed:39636148 PMC:PMC11784101 OpenAlex:https://openalex.org/W4405074097

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: R15AI157907

HHS | NIH | National Institute of General Medical Sciences

Grant: 1F33GM130382

NIGMS NIH HHS

Grant: F33 GM130382

NIGMS NIH HHS

Grant: T32 GM146694

NIGMS NIH HHS

Grant: R25 GM119970

National Institutes of Health

Grant: 1F33GM130382-01X1

Comparative proteomics: The KSHV Ubiquitome in Latency and Reactivation

National Institutes of Health

Grant: 4R15AI157907-02

The KSHV Ubiquitome: Developing a CURE (Course-based undergraduate research experience)

FWCI

0.63

Citation Percentile

0.7%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1128/jvi.01224-24

HYBRIDhttps://doi.org/10.1128/jvi.01224-24

publisherhttps://doi.org/10.1128/jvi.01224-24

publisherhttps://journals.asm.org/doi/pdf/10.1128/jvi.01224-24

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39636148

Fields of Study

Ubiquitin and proteasome pathwaysViral-associated cancers and disordersHistone Deacetylase Inhibitors ResearchMedicineBiology0301 basic medicine0303 health sciences03 medical and health sciencesHerpesvirus 8, HumanHumansProteomeImmediate-Early ProteinsUbiquitinVirus ActivationSarcoma, KaposiTrans-ActivatorsVirus LatencyHost-Pathogen InteractionsUbiquitinationSumoylation

MeSH Terms

HumansSarcoma, KaposiVirus ActivationVirus ReplicationTrans-ActivatorsVirus LatencyImmediate-Early ProteinsHerpesvirus 8, HumanProteomeUbiquitinUbiquitinationHost-Pathogen InteractionsHEK293 CellsSumoylation

Keywords

BiologyLytic cycleVirologyUbiquitinKaposi's sarcoma-associated herpesvirusUbiquitin-Protein LigasesHost (biology)ProteomeSarcomaHuman herpesvirusGammaherpesvirinaeHerpesviridaeUbiquitin ligaseVirusCancer researchGeneticsViral diseaseGeneProteomicsMajor histocompatibility complexImmune EvasionE3 LigaseHuman HerpesvirusesUbiquitinationSumoylationVirus-Cell InteractionsImmediate-Early ProteinsVirus LatencyKaposi's sarcoma-associated herpesvirus; e3 ligase; human herpesviruses; immune evasion; major histocompatibility complex; proteomics; ubiquitinHerpesvirus 8, HumanHost-Pathogen InteractionsTrans-ActivatorsHumansVirus ActivationSarcoma, Kaposi

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being